|
Jan 16
|
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
|
|
Jan 16
|
Pleco Therapeutics receives FDA Orphan Drug Designation
|
|
Dec 26
|
Hyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)
|
|
Dec 21
|
Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome
|
|
Dec 4
|
Hyloris announces US FDA approval for Podofilox Gel
|
|
Oct 24
|
Hyloris Announces Out-Licensing of Atomoxetine Oral Liquid in Canada
|
|
Oct 18
|
Hyloris Pharma wins US FDA approval for pain treatment
|
|
Oct 18
|
Hyloris announces U.S. FDA Approval of Maxigesic® IV
|